Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice
Satoshi Iwai, Kosuke Kaji, Norihisa Nishimura, Takahiro Kubo, Fumimasa Tomooka, Akihiko Shibamoto, Junya Suzuki, Yuki Tsuji, Yukihisa Fujinaga, Koh Kitagawa, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji
Topics & Concepts
EndocrinologyInternal medicineSkeletal muscleSemaglutideMuscle atrophyProtein degradationMyocyteChemistryLiraglutideBiologyMedicineType 2 diabetesDiabetes mellitusBiochemistryMuscle Physiology and DisordersNutrition and Health in AgingMetabolism, Diabetes, and Cancer